Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Fixed Cycle and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Part B of ADAPT NXT

              Author:Gwathmey, Kelly   Bril, Vera   Habib, Ali A.   Claeys, Kristl G.   Hussain, Yessar   Sahagian, Gregory   Cortés-Vicente, Elena   Brauer, Edward   Guptill, Jeff   Gelinas, Deborah   Liu, Li   Jimenez, Rosa H.   Masschaele, Delphine   Mantegazza, Renato   Meisel, Andreas   Sun, Fang   Att,   

              Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P1.004  

              Author Institution:Austin Neuromuscular Center, Austin, TX  argenx, Ghent, Belgium  Charité – Universitätsmedizin Berlin, Berlin, Germany  

              Long-term Safety and Efficacy of Subcutaneous Efgartigimod PH20 in Adult Participants with Generalized Myasthenia Gravis: Interim Results of the ADAPT-SC+ Study

              Author:Vu, Tuan   Li, Yuebing   Howard Jr, James F.   Korobko, Denis   Steeland, Sophie   Van Hoorick, Benjamin   Podhorna, Jana   Hodari, Moana   Utsugisawa, Kimiaki   Sacca, Francesco   De Bleecker, Jan L.   Mantegazza, Renato   

              Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P1.005  

              Author Institution:State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russian Federation  argenx, Zwijnaarde, Belgium  argenx, Ghent, Belgium  Hanamaki General Hospital, Hanamaki, Japan  Federico II University of Naples, Napoli, Italy  

              Oral Cladribine Capsules for Generalized Myasthenia Gravis: Design of the Actively Recruiting Phase 3 MyClad Study

              Author:Rejdak, Konrad   Howard Jr., James F.   Cutter, Gary   O'Connor, Kevin   Dimachkie, Mazen   Palace, Jacqueline   Meisel, Andreas   Mantegazza, Renato   Nolting, Axel   Gopalakrishnan, Sathej   Le Bolay, Claire   Javor, Andrija   Alexandri, Nektaria   Jack, Dominic   Kaminski, Henry   

              Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P1.013  

              Author Institution:Medical University of Lublin, Lublin, Poland  University of Alabama at Birmingham, Birmingham, AL  Yale School of Medicine, Yale University , New Haven, CT  University of Kansas Medical Center, Kansas City, KS  University of Oxford, Oxford, United Kingdom  Charité – Universitätsmedizin Berlin, Berlin, Germany  IRCCS Carlo Besta, Milan, Italy  The healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany  Merck Santé S.A.S., an affiliate of the healthcare business of Merck KGaA, Darmstadt, Germany, Lyon, France  Ares Trading SA, an affiliate of the healthcare business of Merck KGaA, Darmstadt, Germany, Eysins, Switzerland  Merck Serono Ltd., an affiliate of the healthcare business of Merck KGaA, Darmstadt, Germany, Middlesex, United Kingdom  School of Medicine and Health Sciences, George Washington University, Washington, DC  

              Combined Analyses of Participants with Anti-Acetylcholine Receptor Seronegative Generalized Myasthenia Gravis Treated with Efgartigimod Across Clinical Studies

              Author:Bril, Vera   Brauer, Edward   Howard Jr, James F.   Vu, Tuan   Mantegazza, Renato   Meisel, Andreas   Utsugisawa, Kimiaki   

              Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P1.029  

              Author Institution:

              COVID-19 Vaccination Response in Participants Across Clinical Trials Investigating Efgartigimod PH20 SC

              Author:Habib, Ali A.   Vu, Tuan   Saccà, Francesco   Howard Jr, James F.   Sleasman, John W.   Gistelinck, Fien   Duncombe, Paul   Van Hoorick, Benjamin   Steeland, Sophie   Mantegazza, Renato   De Bleecker, Jan L.   Azar, Antoine   Winthrop, Kevin   

              Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Preclinical Studies, Drug Safety, and Health Economics  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P9.029  

              Author Institution:argenx, Zwijnaarde, Belgium  Oregon Health and Science University, Portland, OR